Annual report pursuant to Section 13 and 15(d)

Stock Options

v3.20.2
Stock Options
12 Months Ended
Aug. 31, 2020
Share-based Payment Arrangement [Abstract]  
Stock Options

13.

Stock Options

 

 

 

The Company has established its 2014 Stock Option Plan whereby the board of directors may, from time to time, grant up to 2,107,500 stock options to directors, officers, employees, and consultants, and the 2019 Equity Incentive Plan whereby the board of directors may, from time to time, grant up to 7,838,713 stock options to directors, officers, employees, and consultants. Stock options granted must be exercised no later than five years from the date of grant or such lesser period as determined by the Company’s board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company’s common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors.

 

During the year ending August 31, 2020 the formerly established 2007 Equity Incentive Plan and the 2010 Stock Option Plan were cancelled. Outstanding options were cancelled and reissued under the 2019 Equity Incentive Plan.

 

 

Fiscal 2020 Activity

 

The Company granted stock options in the year ending August 31, 2020:

  

Quantity

 

Exercise Price $

Life (Years)

1,000,000

 

0.55

5

60,000

 

0.43

5

550,000

 

0.47

5

2,538,000

 

0.32

5

700,000

0.

0.34

5

4,848,000

(1)

0.39

5

(1) 3,962,000 have vested as at August 31, 2020, and 886,000 remain subject to vesting provisions.

 

Fiscal 2019 Activity

 

The Company granted stock options in the year ending August 31, 2019:

 

Quantity

Exercise Price $

Life (Years)

390,000(1)

1.27

5

240,000(1)

1.06

5

30,000(1)

1.16

5

350,000

0.99

5

440,000(1)

0.99

5

48,000(1)

0.96

5

100,000

0.81

5

450,000(1)

0.81

5

2,048,000

1.00

 

(1) Options granted vest over a period of three years

 

A continuity schedule for stock options is presented below:

 

 

 

Options

 

 

Weighted Average Exercise Price $

 

 

Weighted Average Remaining Contractual Term (Years)

 

 

Aggregate Intrinsic Value $

 

Balance August 31, 2018

 

 

4,800,000

 

 

 

0.71

 

 

 

 

 

 

 

Expired/Cancelled

 

 

(1,415,000 )

 

 

0.66

 

 

 

 

 

 

 

Exercised

 

 

(430,000 )

 

 

0.15

 

 

 

 

 

 

 

Granted

 

 

2,048,000

 

 

 

1.00

 

 

 

 

 

 

 

Balance August 31, 2019

 

 

5,003,000

 

 

 

0.71

 

 

 

 

 

 

 

Expired/Cancelled

 

 

(4,483,000 )

 

 

0.98

 

 

 

 

 

 

 

Exercised

 

 

(220,000 )

 

 

0.14

 

 

 

 

 

 

 

Granted

 

 

4,848,000

 

 

 

0.39

 

 

 

 

 

 

 

Balance August 31, 2020 (Outstanding)

 

 

5,148,000

 

 

 

0.37

 

 

 

4.30

 

 

 

140,634

 

Balance August 31, 2020 (Exercisable)

 

 

4,262,000

 

 

 

0.34

 

 

 

4.29

 

 

 

136,853

 

 

The fair value of options granted was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

 

 

 

August 31

2020

 

 

August 31

2019

 

Expected volatility

 

95%- 96

%

 

100%- 144

%

Risk-free interest rate

 

0.35%- 1.66

%

 

1.42%- 2.89

Expected life

 

5 years

 

 

5 years

 

Dividend yield

 

 

0 %

 

 

0 %

Estimated fair value per option

 

$0.31-$0.54

 

 

$0.60 - $1.07